Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Hwang

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Plos One|August 17, 2013
Stock market returns and clinical trial results of investigational compounds: an event study analysis of large biopharmaceutical companiesThomas J Hwang
JCO Oncology Practice|January 19, 2023
Reply to E. Noguchi et alThomas J Hwang
JAMA|May 29, 2025
Challenges in Delivering Most-Favored-Nation Pricing for Prescription Drugs in the USThomas J Hwang, Luca Maini
Nature|August 27, 2024
Urgently clarify how AI can be used in medicine under new EU lawThomas J Hwang, Prokar Dasgupta
International Journal of Cancer|October 31, 2018
Association between progression-free survival and patients' quality of life in cancer clinical trialsThomas J Hwang, Bishal Gyawali
Plos Medicine|October 1, 2014
Global financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatmentThomas J Hwang, Salmaan Keshavjee
The Journal of Antimicrobial Chemotherapy|February 14, 2014
Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a national cross-sectional studyThomas J Hwang, David C Hooper
JAMA|January 24, 2017
The Pediatric Research Equity Act Moves Into AdolescenceFlorence T Bourgeois, Thomas J Hwang
The New England Journal of Medicine|October 10, 2022
New Federal Incentives for Diversity in Clinical TrialsThomas J Hwang, Otis W Brawley
The Lancet. Oncology|July 28, 2022
New legislation to promote paediatric studies for new cancer medicinesThomas J Hwang, Florence T Bourgeois
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Plos One|August 17, 2013
Stock market returns and clinical trial results of investigational compounds: an event study analysis of large biopharmaceutical companiesThomas J Hwang
JCO Oncology Practice|January 19, 2023
Reply to E. Noguchi et alThomas J Hwang
JAMA|May 29, 2025
Challenges in Delivering Most-Favored-Nation Pricing for Prescription Drugs in the USThomas J Hwang, Luca Maini
Nature|August 27, 2024
Urgently clarify how AI can be used in medicine under new EU lawThomas J Hwang, Prokar Dasgupta
International Journal of Cancer|October 31, 2018
Association between progression-free survival and patients' quality of life in cancer clinical trialsThomas J Hwang, Bishal Gyawali
Plos Medicine|October 1, 2014
Global financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatmentThomas J Hwang, Salmaan Keshavjee
The Journal of Antimicrobial Chemotherapy|February 14, 2014
Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a national cross-sectional studyThomas J Hwang, David C Hooper
JAMA|January 24, 2017
The Pediatric Research Equity Act Moves Into AdolescenceFlorence T Bourgeois, Thomas J Hwang
The New England Journal of Medicine|October 10, 2022
New Federal Incentives for Diversity in Clinical TrialsThomas J Hwang, Otis W Brawley
The Lancet. Oncology|July 28, 2022
New legislation to promote paediatric studies for new cancer medicinesThomas J Hwang, Florence T Bourgeois
Pageof 10